Development of Safe and Non-Self-Immunogenic Mucosal Adjuvant by Recombinant Fusion of Cholera Toxin A1 Subunit with Protein Transduction Domain
Potential use of cholera toxin (CT) as a mucosal vaccine adjuvant has been documented in a variety of animal models. However, native CT is highly toxic to be used as a mucosal adjuvant in humans. Here, we demonstrate a new approach to generate a mucosal adjuvant by replacing the B subunit of CT with...
Guardado en:
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Wiley
2018-01-01
|
| Colección: | Journal of Immunology Research |
| Acceso en línea: | http://dx.doi.org/10.1155/2018/9830701 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|